Last updated on March 2018

A clinical trial sponsored by Pfizer for a research study for the treatment of Alopecia, Alopecia Areata


Brief description of study

This is a Phase 2a, randomized, double blind, parallel group, multicenter study with an extension period. The study will have a maximum duration of approximately 85 weeks. This includes an up to 5 weeks screening period, a 24 week treatment period, a 4 week drug holiday, an up to 12 month extension period, and a 4 week follow up period. The study will enroll a total of approximately 132 subjects. The study will be conducted at approximately 30 to 40 sites.

Clinical Study Identifier: NCT02974868

Contact Investigators or Research Sites near you

Start Over

University of Alabama at Birmingham
Birmingham, AL United States

Southern California Dermatology, Inc.
Santa Ana, CA United States

Clinical Science Institute
Santa Monica, CA United States

University of Colorado Hospital Clinical and Translational Research Center, Inpatient Unit
Aurora, CO United States

University of Colorado Hospital Clinical and Translational Research Center, Outpatient Clinic
Aurora, CO United States

University of Colorado Hospital, Anschutz Cancer Pavilion
Aurora, CO United States

Yale New Haven Hospital - Radiology
New Haven, CT United States

Yale School of Medicine
New Haven, CT United States

Investigational Drug Services
New Haven, CT United States

Church Street Research Unit
New Haven, CT United States

Park Avenue Dermatology Administrative Annex
Orange Park, FL United States

Park Avenue Dermatology
Orange Park, FL United States

Olympian Clinical Research
Tampa, FL United States

Rose Radiology
Tampa, FL United States

Forward Clinical Trials, Inc
Tampa, FL United States

MedaPhase Inc.
Newnan, GA United States

NorthShore University HealthSystem Dermatology Clinical Trials Unit
Skokie, IL United States

Dawes Fretzin Clinical Research Group, LLC
Indianapolis, IN United States

Dawes Fretzin Dermatology Group, LLC
Indianapolis, IN United States

Tufts Medical Center
Boston, MA United States

Massachusetts General Hospital Clinical Unit for Research Trials in Skin (CURTIS)
Boston, MA United States

Icahn School of Medicine at Mount Sinai
New York, NY United States

Mount Sinai Department of Otolaryngology
New York, NY United States

Rockefeller University Hospital
New York, NY United States

Investigational Drug Service
Rochester, NY United States

University of Rochester Medical Center
Rochester, NY United States

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK United States

Health Concepts
Rapid City, SD United States

University of Utah MidValley Dermatology
Murray, UT United States

University of Utah Medical Center
Salt Lake City, UT United States

Virginia Clinical Research, Inc.
Norfolk, VA United States

St George Dermatology and Skin Cancer Centre
Kogarah, Australia

The Skin Centre
Benowa, Australia

Veracity Clinical Research
Woolloongabba, Australia

Skin & Cancer Foundation Inc.
Carlton, Australia

Sinclair Dermatology
East Melbourne, Australia

Wiseman Dermatology Research Inc.
Winnipeg, MB Canada

Lynderm Research Inc.
Markham, ON Canada

Research by ICLS
Oakville, ON Canada

SKiN Centre for Dermatology
Peterborough, ON Canada

The Centre for Dermatology
Richmond Hill, ON Canada

York Dermatology Center
Richmond Hill, ON Canada

Tower Saint John's Imaging
Santa Monica, CA United States

Office of F. Monte Purcelli, MD
Santa Monica, CA United States

Yale Hearing and Balance Center
New Haven, CT United States

Edward B. Kampsen, MD
Tampa, FL United States